Hemorrhagic transformation after acute ischemic stroke thrombolysis treatment: navigating the landscape of hemostasis genetic risk factors

J Thromb Haemost. 2024 Apr;22(4):919-921. doi: 10.1016/j.jtha.2024.01.002.

Author

Zsuzsa Bagoly¹

Affiliation

¹ Division of Clinical Laboratory Science, Department of Laboratory Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary; HUN-REN-DE Cerebrovascular Research Group, Debrecen, Hungary. Electronic address: bagoly@med.unideb.hu.

PMID: 38521577
DOI: 10.1016/j.jtha.2024.01.002

No abstract available

MeSH terms

Brain Ischemia* / diagnosis
Brain Ischemia* / drug therapy
Brain Ischemia* / genetics
Cerebral Hemorrhage / chemically induced
Fibrinolytic Agents / adverse effects
Hemostasis
Humans
Ischemic Stroke*
Risk Factors
Stroke* / diagnosis
Stroke* / drug therapy
Stroke* / genetics
Thrombolytic Therapy / adverse effects
Tissue Plasminogen Activator / adverse effects

Substances

Tissue Plasminogen Activator
Fibrinolytic Agents